Business Leaders

Age : 57

Public asset : 692,712 USD

Linked companies :

Summary

Currently, Karin Jooss is Executive VP & Head-Research & Development at Gritstone bio, Inc. Dr. Jooss is also on the board of Fate Therapeutics, Inc.

Dr. Jooss previously held the position of Head-Cancer Immunotherapeutics at Pfizer Inc. and Vice President-Research at Cell Genesys, Inc.

Karin Jooss received a doctorate from Philipps University of Marburg.

Current positions of Karin Jooss

Name	Title	Since
Gritstone bio, Inc. (Pharmaceuticals)	Executive VP & Head-Research & Development	2021
Fate Therapeutics, Inc. (Biotechnology & Medical Research)	Independent Director	2019

Holdings of Karin Jooss

Name	Equities	%	Valuation
Gritstone bio, Inc. (GRTS) (Pharmaceuticals)	355,204	0.38%	674,888 USD
Fate Therapeutics, Inc. (FATE) (Biotechnology & Medical Research)	9,848	0.0100%	17,825 USD

Karin Jooss: Personal Network

Name	Linked companies
Shefali Agarwal	Fate Therapeutics, Inc. Gritstone bio, Inc.
Sarah Cooley	Fate Therapeutics, Inc.
Robert M. Hershberg	Fate Therapeutics, Inc.
Wen Bo Wang	Fate Therapeutics, Inc.
Bahram Valamehr	Fate Therapeutics, Inc.
Edward Dulac	Fate Therapeutics, Inc.
Cindy R. Tahl	Fate Therapeutics, Inc.
Robert S. Epstein	Fate Therapeutics, Inc.
Michael Stewart Lee	Fate Therapeutics, Inc.
Jim Beitel	Fate Therapeutics, Inc.